DIA420.55-0.96 -0.23%
SPX5,892.58+6.03 0.10%
IXIC19,146.81+136.72 0.72%

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga·10/07/2024 16:31:00
Listen to the news

Gainers

  • Scholar Rock Holding (NASDAQ:SRRK) shares moved upwards by 324.2% to $31.48 during Monday's regular session. The company's market cap stands at $2.5 billion.
  • LogicMark (NASDAQ:LGMK) shares increased by 17.27% to $0.13. The market value of their outstanding shares is at $1.5 million.
  • Cue Biopharma (NASDAQ:CUE) stock increased by 16.37% to $1.35. The company's market cap stands at $81.2 million.
  • Akoya Biosciences (NASDAQ:AKYA) stock moved upwards by 15.82% to $3.22. The company's market cap stands at $159.3 million.
  • WORK Medical Technology (NASDAQ:WOK) stock moved upwards by 15.49% to $5.44. The company's market cap stands at $79.3 million.
  • iBio (AMEX:IBIO) stock rose 14.84% to $2.52. The market value of their outstanding shares is at $21.7 million.

Losers

  • Trevena (NASDAQ:TRVN) shares declined by 45.0% to $2.54 during Monday's regular session. The market value of their outstanding shares is at $2.1 million.
  • Galecto (NASDAQ:GLTO) shares decreased by 26.03% to $8.64. The company's market cap stands at $10.7 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock declined by 24.25% to $5.75. The company's market cap stands at $2.9 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock fell 19.0% to $0.52. The market value of their outstanding shares is at $2.5 million.
  • Virios Therapeutics (NASDAQ:VIRI) stock declined by 15.84% to $0.14. The market value of their outstanding shares is at $3.9 million.
  • Meihua Intl Medical Techs (NASDAQ:MHUA) stock decreased by 13.46% to $0.9. The market value of their outstanding shares is at $22.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.